Playback speed
10 seconds
CML State of the Art: Dasatinib/Imatinib Dose Optimization, STAMPi Asciminib Efficacy in CP-CML, Treatment Free Remission, Single Cell Analysis
55 views
February 5, 2021
Login to view comments.
Click here to Login